Enable Injections Partners with Flex for Wearable Injector Production


Reading time ( words)

Enable Injections Inc., the developer and manufacturer of wearable medical devices that enable easy patient self-administration of high volume injectable drugs, has entered into a product development and manufacturing partnership with Flex, the global sketch-to-scale solutions company that designs and builds intelligent products for a connected world.

As part of the deal, Enable Injections and Flex will collaborate on the design, development and production of customized wearable injector systems for pharmaceutical company products and clinical trials.

"Effective design of wearable medical devices requires that we innovate on multiple fronts, pushing the boundaries of wearable technology, medical device development, and manufacturing processes," said Paul Humphries, president of High Reliability Solutions at Flex. "With their track record of quality and innovation, Enable Injections is an ideal partner in this process. We are proud to have been selected as Enable Injections’ manufacturing partner, and thrilled to be helping bring innovative, high quality wearable medical devices to the pharmaceutical and biotech industries."

According to Enable Injections, the company's novel injectors – based on pain-free injection technology and preferred by patient panels – provide customers with numerous advantages, including:

  • Subcutaneous delivery of up to 50mL doses of high volume and/or viscous biologics
  • Ability to monitor compliance and capture data utilizing optional Bluetooth connectivity and a mobile app to provide a connected healthcare solution
  • Passive warming of drug product, eliminating the 30-minute wait for refrigerated vials to reach room temperature
  • Automated mixing and reconstitution, reducing formulation time and drug development costs
  • Use of standard vials, cartridges and syringes, and existing container closures
  • Facilitation of in-home therapy, reducing healthcare system costs

"Flex is the recognized leader in high volume manufacturing of body-worn injection systems. We very much look forward to partnering with Flex to satisfy pharmaceutical and biotech company requirements for high reliability, high volume manufacturing," said Michael D. Hooven, Enable Injections' president and CEO.

Share

Print


Suggested Items

Laserssel Brings High-speed Soldering to New Application Areas

06/10/2019 | Barry Matties, I-Connect007
In this interview with I-Connect007, Denis Barbini, general manager of Laserssel, talks about the company's new laser-selective reflow solution aimed at reducing a typical reflow oven’s 10-minute cycle down to just 10 seconds as well as the overall benefits manufacturers could see from streamlining this process.

Flex Circuit Supply Chain Challenges

02/13/2019 | Stephen Las Marias, I-Connect007
In our recent Flex and Rigid-Flex survey, we asked the following question: "Do you have problems with your flex circuit supply chain?" Below are just a few of the explanations of those who answered "Yes", slightly edited for clarity.

Top 10 Most-Read SMT Interviews of 2018

01/04/2019 | Stephen Las Marias, I-Connect007
We continue our top 10 lists, this time with the most-read SMT interviews in 2018. Topping the list is an interview with Joe O’Neil and Matthew Becker of Power Design Services (PDS), along with Ted Park of Green Circuits, who announced their merger last year.



Copyright © 2020 I-Connect007. All rights reserved.